GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT Jayamas Medica Industri Tbk (ISX:OMED) » Definitions » Net Change in Cash

PT Jayamas Medica Industri Tbk (ISX:OMED) Net Change in Cash : Rp-31,525 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is PT Jayamas Medica Industri Tbk Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

PT Jayamas Medica Industri Tbk's Net Change in Cash for the three months ended in Mar. 2024 was Rp22,544 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was Rp-31,525 Mil.

PT Jayamas Medica Industri Tbk Net Change in Cash Historical Data

The historical data trend for PT Jayamas Medica Industri Tbk's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Jayamas Medica Industri Tbk Net Change in Cash Chart

PT Jayamas Medica Industri Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
157,911.29 380,814.78 35,812.13 97,708.27 290,023.47

PT Jayamas Medica Industri Tbk Quarterly Data
Dec19 Dec20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 344,092.20 -207,638.87 57,117.89 96,452.26 22,543.89

PT Jayamas Medica Industri Tbk Net Change in Cash Calculation

PT Jayamas Medica Industri Tbk's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=134354.12+264593.611+-110578.446+1654.188
=290,023

PT Jayamas Medica Industri Tbk's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=52101.382+-15687.024+-13386.75+-483.715
=22,544

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-31,525 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Jayamas Medica Industri Tbk Net Change in Cash Related Terms

Thank you for viewing the detailed overview of PT Jayamas Medica Industri Tbk's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Jayamas Medica Industri Tbk (ISX:OMED) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT Jayamas Medica Industri Tbk (ISX:OMED) » Definitions » Net Change in Cash
Comparable Companies
ISX:MARK ISX:MEDS ISRG XPAR:EL BDX TSE:7741 XSWX:ALC WST OCSE:COLO B RMD TSE:4543 XSWX:STMN XPAR:DIM BAX TSE:7733 HOLX COO TSE:6869 SZSE:300896 TFX
Traded in Other Exchanges
N/A
Address
Sebelah Selatan Jalan By Pass RT 05 / RW 01, Kelurahan Sidomojo, Kecamatan Krian, Sidoarjo, Jawa Timur, East Java, IDN, 61262
Website
https://www.onemed.co.id
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing medical devices and other household health supplies. It initially began with the manufacture of urine bags, OneMed later expanded in the manufacturing business of medical equipment and supplies in Indonesia with a range of variants of products manufactured locally. The Company and its Subsidiaries has three main divisions: Manufacturing; Distribution and Retail.

PT Jayamas Medica Industri Tbk (ISX:OMED) Headlines

From GuruFocus

OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer

By Marketwired Marketwired • 10-22-2018

OncoMed to Present at the Cantor Global Healthcare Conference

By Marketwired Marketwired • 09-24-2018

OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights

By Marketwired Marketwired • 03-15-2019

OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer

By GlobeNewswire GlobeNewswire • 10-20-2018

Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, Inc. ("OncoMed") – Result of OncoMed Stockholder Meeting

By Marketwired Marketwired • 04-18-2019

OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights

By Marketwired Marketwired • 08-02-2018

OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer

By Marketwired Marketwired • 10-20-2018

OncoMed Presents Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer Research Annual Meeting

By Marketwired Marketwired • 04-18-2018

OncoMed to Present at Two Upcoming Investor Conferences in September

By Marketwired Marketwired • 08-29-2018

OncoMed to Present Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer Research Annual Meeting

By Marketwired Marketwired • 04-09-2018